LINDSEY HAYES: Open Payments
NPI 1760906846 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 6 companies in 2025. Trend: 2023 $356 · 2024 $292 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $86 |
| Tris Pharma Inc | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| ABBVIE INC. | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: FANAPT, Dyanavel XR, CAPLYTA, VRAYLAR, COBENFY, REXULTI.
Industry payments across MS — which companies pay providers there.
